乳腺超声结合钼靶X线检测乳腺癌的临床诊断研究

Study on the clinical diagnosis of breast cancer by breast ultrasonography combined with molybdenum target X-ray

目的对乳腺癌患者应用相靶X线与超声联合进行诊断,并分析其诊断的临床价值。方法选择216例患者作为研究对象,均为2015年10月~2016年6月在本院行手术治疗的乳腺癌患者,将其技照投掷法随机分成三组,其中72例仅应用超声检査的患者作为对照组Ⅰ、72例仅应用钼靶X线检查的患者作为对照组Ⅱ,另外72例患者联合钼靶X线与超声进行检查,作为观察组,对比分析三组患者的阳性检出率及钼靶X线与超声两种不同检查方法表现的相似与不同之处。结果对照组Ⅰ阳性50例(69.44%),对照组Ⅱ阳性51例(70.83%),两组之间差异无统计学意义(P>0.05),观察组阳性检出71例(98.61%),与对照组比较,差异有统计学意义(P<0.05);72例观察组患者中超声诊断出淋巴结(65.2.8%)与肿块表现率(97.22%)显著高于钼靶X线淋巴结(38.89%)与肿块表现率(70.83%),而钼靶X线诊断出钙化(40.28%)与肿块伴钙化表现率(36.11%)明显高于超声的钙化(4.17%)与肿块伴钙化表现率(4.17%),差异有统计学意义(P<0.05)。结论钼靶X线与超声两种方法诊断乳腺癌各有其优点,若结合两种方法共同检查、可大大提高检出阳性率、有利于患者对乳腺癌的早期诊断,建议广泛应用。

Objective To investigate and analyze the clinical value of the diagnosis of breast cancer by molybdenum target X-ray combined with uhrasonography. Methods A total of 216 patients with breast cancer were selected as the study subjects, who were given surgical treatment in our hospital from October 2015 to June 2016. The patients were randomly divided into three groups according to the throwing method. 72 patients who were only given uhrasonography were assigned to the control group I, 72 patients who were only given molybdenum target X-ray were assigned to the control group II , and another 72 patients who were given molybdenum target X-ray combined with ultrasonography were assigned to the observation group. The positive detection rate and the similarities and differences between the two methods of molybdenum target X-ray and uhrasonography were compared and analyzed among the three groups. Results 50 cases （69.44%） were positive in control group I , and 51 cases（70.83%） were positive in the control group Ⅱ. There was no statistically significant difference between the two control groups（P〉0.05）. 71 cases（98.61%） were positive in the observation group, significantly different from that in the control group, and the difference was statistically significant （P〈0.05）; the manifestation rate of lymph nodes（65.28%） and masses（97.22%） by ultrasonography were significantly higher than those of lymph nodes （38.89%） and masses （70.83%） by molybdenum target X-ray in 72 patients in the observation group. The manifestation rate of calcification （40.28%） and masses complicated with calcification （36.11%） by molybde- num target X-ray was significantly higher than that of calcification（4.17%） and masses complicated with calcification by ultrasonography（4.17%）, the differences were statistically significant（P〈0.05）. Conclusion Both molybdenum target X-ray and uhrasonography have different advantages in the diagnosis of breast cancer. If the two methods are combined in the examination, the positive rate of detection can be greatly improved, which is conducive to early diagnosis of breast can- cer, and it is suggested to be widely applied.